MedTrace Logo

Study of Efficacy of Carbamazepine in Therapy of Patients With Moderate Persistent and Severe Bronchial Asthma

NCT00153296 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2009-02-19

No results posted yet for this study

Summary

The purpose of this study was to determine whether antiepileptic drug carbamazepine is effective in the treatment of chronic moderate persistent and severe asthma.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Carbamazepine

Sponsors & Collaborators

  • Rea Rehabilitation Centre, Georgia

    collaborator OTHER

  • Centre of Chinese Medicine, Georgia

    lead OTHER

Principal Investigators

  • Merab Lomia, MD, PhD · "Rea" Rehabilitation Centre

  • Tamuna Tchelidze, MD · CRO Evidence

  • Manana Tchaia, MD · Centre of Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Completion
2005-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00153296 on ClinicalTrials.gov